Galvus 50 mg tablets

DRUG2 trials

Sponsors

Centre Hospitalier Regional Universitaire, Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA

Conditions

Type 2 Diabetes Mellitusrenal transplant

Phase 3

PRODIG : Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early post-transplant period

Not yet recruitingCTIS2024-516272-14-00

Centre Hospitalier Regional Universitairerenal transplant

Target: 186Updated: 2025-01-16

Phase 4

Open-label, double-arm, controlled, randomized, multicentre clinical trial to evaluate the impact of pharmacogenetic-guided treatment in patients with insufficiently controlled type 2 diabetes

Active, not recruitingCTIS2025-520686-46-00

Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVAType 2 Diabetes Mellitus

Start: 2025-05-15Target: 504Updated: 2025-09-15